| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Employee Benefits for Motivation and Productivity of Work |
|
Digg It - Employee Benefits for Motivation and Productivity of Work
Employee benefits are essential for the development of corporate industrial relations. According to Herzberg’s two- According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product factor theory (motivation and hygiene), an employee benefit programme is a necessary and sufficient working conditi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in n. The hygiene factor will affect employees’ work motivation and thus productivity. In the stimulus-response behav lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. iour, employees’ work-motivation, seen as the response, can be analysed from absence rate, leave rate, quit rate, g here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t-to-work speed and so on. Productivity can be analysed from quality and quantity of products. The quality indices d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro include faults and returns. The quantity indices include completion time and the production hygiene factor. This de ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ends on the individual properties of the employee, who is the medium essential for management, and stimulates emplo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi yees to enhance their work and productivity. In addition, everyone works in expectation of some rewards (both spir nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically tual and material), and welfare is one of them. In other words, the degree of reward influences the quality and qua and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ntity of work, and in turn productivity. Hence it is important to explore how to give the stimulus (welfare) in ord ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi r to promote work motivation and productivity. To understand the impact of employee benefit on employees’ work mot ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ivation and productivity, questionnaires were sent to corporations which had undertaken employee benefit programmes dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod Results reflected on a variety of assumptions. Implementation of employee benefit programmes affects employees’ p cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin erformance. Employee benefit programmes have greater impact on work-motivation than on productivity. Monetary benef tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen t programmes are most highly valued by both executives and workers. There is a cognitive gap between management and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel worker on the importance of employee benefit programmes. Private-corporation employees have greater employee benef ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t demands than their public corporation counterparts. Female and male employees have different benefit demands. Sin y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products gle employees perceive more employee benefit impact on job performance than married ones. Employees with different . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ducation levels perceive different employee benefit impact. Employees with different positions perceive different e elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip mployee benefit impacts. Employee benefit programmes have greater influence on job performance of younger employees tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Digital Signage - Out-of-Home Advertising Gains Public Recognition How to Avoid Online Work at Home Jobs Scams Creating a New Standard of Excellence – Six Things You Can Do
|